Rcsiroyal College of Surgeons in Ireland

Total Page:16

File Type:pdf, Size:1020Kb

Rcsiroyal College of Surgeons in Ireland Inside: Targeted treatment for Crohn’s disease Volume 11: Number 1. 2018 ISSN 2009-0838 smj Royal College of Surgeons in Ireland RCSI Student Medical Journal Big budget brain projects RCSI DEVELOPING HEALTHCARE LEADERS WHO MAKE A DIFFERENCE WORLDWIDE Acknowledgements Thank you to RCSI Alumni for their continued support to us as students – providing career advice, acting as mentors, enabling electives and research, and supporting the publication of the RCSIsmj since its inception in 2008. We, as today’s generation of students and tomorrow’s generation of alumni, are very grateful for this ongoing support. A special thanks to Prof. David Smith for the time and encouragement he has given to the RCSIsmj Ethics Challenge and for his support of the annual debate. We would also like to thank the Dean, Prof. Hannah McGee, for her sponsorship, and Margaret McCarthy in the Dean’s Office for her constant endorsement and assistance. The RCSIsmj was extremely privileged to have a number of professors and clinicians involved in this year’s journal club. We would like to thank the following for their support of, and participation in, the journal club, and to express our appreciation of the time, knowledge and expertise they shared with us: Dr Nurul Aminudin Prof. Fionnuala Breathnach Dr Frank Doyle Dr Joseph Galvin Prof. Arnold Hill Prof. Samuel McConkey Dr Mark Murphy Mr David O'Brien RCSIsmjcontents 4 Editorial Royal College of Surgeons in Ireland Student Medical Journal 4 Director’s welcome Executive Committee RCSI Ethics Challenge Director Jenna Geers 5 RCSIsmj Ethics Challenge 2018/2019 Editor-in-Chief Suzanne Murphy Peer Review Director David Maj 6 RCSIsmj Ethics Challenge winner 2017/2018 Senior Editor Rachel Adilman Assistant Peer Review Cameron Chalker Senior Staff Writer Alexandra Mitcham Research spotlight Executive Secretary Oludare Alabi 10 Spotlight on research at RCSI – Prof. Peter Conlon Webmaster Gemma Wright Ballester Interview Peer Reviewers 11 The generalists Andrew Mikhail Matthew McMurray Alison Hunt Case report Jodie Odame Shaghayegh Esfandnia 14 Diagnostic dilemma: a rare cause of lower back pain Elise Halpern Rachel Dharamshi Original articles Tessa Weinberg Monika Cieslak 19 When the brain goes quiet: cortical silence inhibition in schizophrenia Bunmi Adesanya Magar Ghazarian Review articles Moyowa Boyo David Seligman 24 Plastic surgery’s role in aneuploidy Deena Shah 29 The misnomer of the ‘oral contraceptive pill’ Melvin Hoo Chuin Shen Savannah Norman Nadine Copty Staff reviews Sakshi Kirpalaney 35 Doctors and doping in sport Staff Writers 41 Faking it: disease-fighting bacteria and the future of synthetic biology Katie Nolan 46 From womb to withdrawal: born addicted Julia Hunter Jessica Millar 52 Treatment is on target in Crohn’s disease with biologic agents Sumara Jaimungal 59 Out of Africa into a genetic bottleneck: how evolution has shaped modern disease Maria Mikail 67 Are emerging treatments in Parkinson’s disease curative or just buying time? Education Director Claire Gallibois Education Officers Perspectives Catherine Uhomoibhi 73 HPV vaccination: facts versus fears Farah Adamali 77 Making the match Sannihita Vatturi 82 Is a robot reading my x-rays? Public Relations Director Matthew Patel 86 Big budget brain projects Public Relations Officer Melissa Mae Gabriel 91 ‘What’s in a name?’ Book review 95 Fitting in JOURNALISM CONTENT DESIGN The Malthouse, 537 NCR, Dublin 1. Abstracts T: 01-856 1166 F: 01-856 1169 www.thinkmedia.ie 96 Investigating the impact of enhancer methylation on gene expression in metastatic Design: Tony Byrne, Tom Cullen and Niamh Short colorectal cancer Editorial: Ann-Marie Hardiman, Paul O’Grady and Colm Quinn 98 Implications of stroke for informal caregivers: a five-year follow-up Please email comments to [email protected], join our Facebook page, or follow us on Twitter @RCSIsmj to discuss journal articles. Submissions to [email protected]. See www.rcsismj.com to find out more, see past editions, and follow our blog. Volume 11: Number 1. 2018 | Page 3 RCSIsmjeditorial and director’s welcome Rising to the challenges of research James Bryce once said: “Medicine [is] the only profession that labors campaign can have on a vaccination programme. Senior staff writer incessantly to destroy the reason for its existence”. Alexandra Mitcham examines the role of doctors in doping in sports, and considers our ethical obligations as healthcare professionals. Medicine is a constantly evolving field, striving to move forward even Finally, Carol Rizkalla looks at how we define illness. Through simple when it can seem impossible. As healthcare professionals we attempt to semantics we could be allowing the development of eugenics as halt the disease process and give our patients an acceptable quality of genome editing fails to clarify certain key research terms. In a world that life. In the 11 years since the RCSIsmj was founded, healthcare has seen is constantly moving, we need to stop and consider if we are all on the changes that seemed unimaginable in 2007. In this issue we consider same page when it comes to the everyday terminology we use. how, despite such major advances, a significant number of conditions Despite the problems and challenges, the failures and the still require greater research in terms of both understanding the disappointments, research will always continue to push forward, trying condition, and the development of safe and effective treatments. passionately to eradicate disease from this world. This RCSIsmj is, for Furthermore, we look at how the amazing advances of science have also most students, their first experience of taking their initial tentative steps led to problems and ethical questions. Staff writer Jessica Millar looks at on the road towards life-changing research. the evolving therapies for Parkinson’s disease, and asks if they truly have a role in the treatment process. Maria Mikail considers the impact of cortical inhibition on patients with schizophrenia. Katie Nolan examines the recent increase in synthetic biologic agents and questions their future role in treating conditions from E. coli infection to HIV. Constantly striving for advancement creates a double-edged sword and there is potential for new treatments to be misunderstood, misused, or even exploited. Social media, something that would never have previously impacted on healthcare, now has the power to ‘make or break’ a health campaign. Laura Staunton looks at the impact of the HPV Suzanne Murphy vaccine on the wider public and reflects on the effect a negative media Editor-in-Chief, RCSIsmj 2017-2018 Director’s welcome I am delighted and honoured to welcome you to this year’s RCSIsmj. interests in a long view of his research career, and invites students to Over the last 11 years it has been the purpose and pleasure of the boldly move forward according to their own curiosity and drive. RCSIsmj to publish students’ research and original academic writing. Each As the time of my involvement with the RCSIsmj comes to a close, I have edition is part of an entirely student-run process and involves an the privilege of handing over the reins to a truly passionate, intelligent, impressive network of collaboration: students submit their own original and creative staff. As always, we are overwhelmingly grateful to the work, and our peer review team scrutinise submissions after Dean’s office and faculty of RCSI, without whose support this publication anonymisation; based on these recommendations, editorial staff select would not be possible and with whose encouragement the RCSIsmj articles for publication, guide alterations and make suggestions, ensuring continues to go from strength to strength. Finally, I hope that you, like that everything that glitters truly is gold. This year we revamped and me, are awed by the success and innovation of those who have fine-tuned our internal processes so as to best showcase the incredible contributed already and find that this edition spurs you on to greater talent and intelligence of our contributors. engagement with medical research in future! Inspiring students to conduct and engage with research is central to our passion and purpose. Our educational staff help provide students with the tools to scrutinise academic publications, continue to run our popular journal clubs, and host passionate faculty to speak about their own publications and work. Our blog, which this year opened to submissions from any RCSIsmj staff member, will open to submissions from all RCSI students next year as a more informal entry to academic writing. As students at the dawn of our careers, we look to those already in the field for wisdom and inspiration; thus, this year we continue the section spotlighting the research of RCSI faculty. Prof. Peter Conlon, Jenna Geers Associate Professor of Medicine at RCSI, speaks about his enthusiasm and Director, RCSIsmj 2017-2018 Page 4 | Volume 11: Number 1. 2018 RCSIsmjprize Ethics challenge 2018/2019 CONSCIENTIOUS OBJECTION IN MEDICINE In January 2018 the Conscientious Objection (Medical Activities) Bill place on a doctor’s freedom as it protected vulnerable patients from received a second reading in the United Kingdom’s House of Lords. harm.4 In the United Kingdom2 and Australia5 doctors are permitted This Bill seeks to clarify the extent to which a medical practitioner to refuse women a termination of pregnancy if they object on with a conscientious objection may refrain from participating in religious or moral grounds; however, they are expected
Recommended publications
  • Basic Concepts in Basic Concepts in Dysmorphology
    Basic Concepts in Dysmorphology Samia Temtamy* & Mona Aglan** *Professor of Human Genetics **Professor of Clinical Genetics Human Genetics & Genome Research Division National Research Centre, Cairo, Egypt OtliOutline y Definition of dysmorphology y Definition of terms routinely used in the description of birth defects y Impact of malformations y The difference between major & minor anomalies y Approach to a dysmorphic individual: y Suspicion & analysis y Systematic physical examination y CfitifdiConfirmation of diagnos is y Intervention y Summary 2 DfiitiDefinition of fd dysmorph hlology y The term “dysmorphology” was first coined by Dr. DidSithUSAiDavid Smith, USA in 1960s. y It implies study of human congenital defects and abnormalities of body structure that originate before birth. y The term “dysmorphic” is used to describe individuals whose physical fffeatures are not usually found in other individuals with the same age or ethnic background. y “Dys” (Greek)=disordered or abnormal and “Morph”=shape 3 Definition of terms routinely used in the d escri pti on of bi rth d ef ect s y A malformation / anomaly: is a primary defect where there i s a bas ic a ltera tion o f s truc ture, usuall y occurring before 10 weeks of gestation. y Examples: cleft palate, anencephaly, agenesis of limb or part of a limb. 4 Cleft lip & palate Absence of digits (ectrodactyly) y Malformation Sequence: A pattern of multiple defects resulting from a single primary malformation. y For example: talipes and hydrocephalus can result from a lumbar neural tube defect. Lumbar myelomeningeocele 5 y Malformation Syndrome: A pattern of features, often with an underlying cause, that arises from several different errors in morphogenesis.
    [Show full text]
  • Dysmorphology Dysmorphism
    Dysmorphology Carolyn Jones, M.D., PhD Dysmorphism Morphologic developmental abnormalities. This may been seen in many syndromes of genetic or environmental origin. 1 Malformation A recognized dysmorphic feature. A structure not formed correctly. This can either be the cause of genetic factors or environment. 2 Deformation An external force resulting in the inability of a structure to form correctly. Example: club feet in a woman with oligohydramnios, fibroid tumors or multiple gestation. Disruption Birth defect resulting from the destruction of a normally forming structure. This can be caused by vascular occlusion, teratogen, or rupture of amniotic sac (amniotic band syndrome). 3 Common Dysmorphic features Wide spacing between eyes, hypertelorism Narrow spacing between eyes, hypotelorism Palpebral fissure length Epicanthal folds Common Dysmorphic Features Philtrum length Upper lip Shape of nose 4 Syndrome A number of malformations seen together Cause of Syndromes Chromosomal aneuploidy Single Gene abnormalities Teratogen exposure Environmental 5 Chromosomal Aneuploidy Nondisjuction resulting in the addition or loss of an entire chromosome Deletion of a part of a chromosome Microdeletion syndromes (small piece missing which is usually only detected using special techniques) 6 Common Chromosomal Syndromes caused by Nondisjuction Down syndrome (trisomy 21) Patau syndrome (trisomy 13) Edwards syndrome (trisomy 18) Turner syndrome (monosomy X) Klinefelter syndrome (47,XXY) Clinical Features at birth of Down syndrome Low set small ears Hypotonia Simian crease Wide space between first and second toe Flat face 7 Clinical Features of Down Syndrome Small stature Congenital heart defects (50-70%) Acquired and congenital hearing impairment. Duodenal atresia Hirshprungs disease Trisomy 13 Occurs in 1/5000 live births.
    [Show full text]
  • Medical Genetics and Genomic Medicine in the United States of America
    View metadata, citation and similar papers at core.ac.uk brought to you by CORE provided by George Washington University: Health Sciences Research Commons (HSRC) Himmelfarb Health Sciences Library, The George Washington University Health Sciences Research Commons Pediatrics Faculty Publications Pediatrics 7-1-2017 Medical genetics and genomic medicine in the United States of America. Part 1: history, demographics, legislation, and burden of disease. Carlos R Ferreira George Washington University Debra S Regier George Washington University Donald W Hadley P Suzanne Hart Maximilian Muenke Follow this and additional works at: https://hsrc.himmelfarb.gwu.edu/smhs_peds_facpubs Part of the Genetics and Genomics Commons APA Citation Ferreira, C., Regier, D., Hadley, D., Hart, P., & Muenke, M. (2017). Medical genetics and genomic medicine in the United States of America. Part 1: history, demographics, legislation, and burden of disease.. Molecular Genetics and Genomic Medicine, 5 (4). http://dx.doi.org/10.1002/mgg3.318 This Journal Article is brought to you for free and open access by the Pediatrics at Health Sciences Research Commons. It has been accepted for inclusion in Pediatrics Faculty Publications by an authorized administrator of Health Sciences Research Commons. For more information, please contact [email protected]. GENETICS AND GENOMIC MEDICINE AROUND THE WORLD Medical genetics and genomic medicine in the United States of America. Part 1: history, demographics, legislation, and burden of disease Carlos R. Ferreira1,2 , Debra S. Regier2, Donald W. Hadley1, P. Suzanne Hart1 & Maximilian Muenke1 1National Human Genome Research Institute, National Institutes of Health, Bethesda, Maryland 2Rare Disease Institute, Children’s National Health System, Washington, District of Columbia Correspondence Carlos R.
    [Show full text]
  • Patients with Noonan Syndrome Phenotype: Spectrum of Clinical Features and Congenital Heart Defect S
    Article PATIENTS WITH NOONAN SYNDROME PHENOTYPE: SPECTRUM OF CLINICAL FEATURES AND CONGENITAL HEART DEFECT S. Nshuti1,*, C. Hategekimana1,*, A. Uwineza2,, J. Hitayezu2, J. Mucumbitsi4, E. K. Rusingiza5, L. Mutesa2,# *These authors contributed equally to this work 1 Faculty of Medicine, National University of Rwanda, Butare, Rwanda; 2 Center for Medical Genetics, Faculty of Medicine, National University of Rwanda, Butare, Rwanda; Center for Human Genetics, CHU Sart Tilman, University of Liège, Belgium; 4 Department of Pediatrics, King Faysal Hospital, Kigali, Rwanda; 5 Department of Pediatrics, Kigali University Teaching Hospital, National University of Rwanda, Kigali, Rwanda; ABSTRACT Mutations in components of the RAS-MAPK signaling pathway have been reported to result in an expression of Noonan phenotype. This is actually a wide-spectrum-phenotype shared by Noonan syndrome and its clinically related disorders namely, the Cranio-facio-cutaneous (CFC) syndrome, Costillo syndrome as well as LEOPARD syndrome. Patients with Noonan Syndrome (NS) have mutations in PTPN11 gene in majority of cases. Recently, mutations in SOS1, RAF1, MEK1 and KRAS genes have been reported to cause NS as well. Objective: To report patients with a Noonan phenotype followed in Rwandan University Teaching Hospitals, and to show the importance of the clinical diagnosis and challenges of making the diagnosis in resource limited settings where karyotype is almost the only genetic investigation accessible. Patients and Methods: Here we are reporting 5 patients, all with relevant NS symptoms, whose morbidity is directly related to the severity of their congenital heart disease. Van der burgt et al diagnostic criteria have been used for the clinical diagnosis, karyotype studies have been performed to exclude chromosomal aberration disorders and patients DNA extraction for mutation studies have been obtained in some cases.
    [Show full text]
  • Medical Genetics and Genomic Medicine in the United States of America
    Himmelfarb Health Sciences Library, The George Washington University Health Sciences Research Commons Pediatrics Faculty Publications Pediatrics 7-1-2017 Medical genetics and genomic medicine in the United States of America. Part 1: history, demographics, legislation, and burden of disease. Carlos R Ferreira George Washington University Debra S Regier George Washington University Donald W Hadley P Suzanne Hart Maximilian Muenke Follow this and additional works at: https://hsrc.himmelfarb.gwu.edu/smhs_peds_facpubs Part of the Genetics and Genomics Commons APA Citation Ferreira, C., Regier, D., Hadley, D., Hart, P., & Muenke, M. (2017). Medical genetics and genomic medicine in the United States of America. Part 1: history, demographics, legislation, and burden of disease.. Molecular Genetics and Genomic Medicine, 5 (4). http://dx.doi.org/10.1002/mgg3.318 This Journal Article is brought to you for free and open access by the Pediatrics at Health Sciences Research Commons. It has been accepted for inclusion in Pediatrics Faculty Publications by an authorized administrator of Health Sciences Research Commons. For more information, please contact [email protected]. GENETICS AND GENOMIC MEDICINE AROUND THE WORLD Medical genetics and genomic medicine in the United States of America. Part 1: history, demographics, legislation, and burden of disease Carlos R. Ferreira1,2 , Debra S. Regier2, Donald W. Hadley1, P. Suzanne Hart1 & Maximilian Muenke1 1National Human Genome Research Institute, National Institutes of Health, Bethesda, Maryland 2Rare Disease Institute, Children’s National Health System, Washington, District of Columbia Correspondence Carlos R. Ferreira, National Human Genome Research Institute, National Institutes of Health, 10 Center Drive, Building 10, Room 10C103, Bethesda, Maryland 20892-1851.
    [Show full text]
  • A Comprehensive Examination of Human Triploidy and Diploid/Triploid Mixoploidy
    A COMPREHENSIVE EXAMINATION OF HUMAN TRIPLOIDY AND DIPLOID/TRIPLOID MIXOPLOIDY by Jason Christopher Carson BS, Allegheny College, 2004 Submitted to the Graduate Faculty of the Graduate School of Public Health in partial fulfillment of the requirements for the degree of Master of Science University of Pittsburgh 2009 UNIVERSITY OF PITTSBURGH GRADUATE SCHOOL OF PUBLIC HEALTH This thesis was presented by Jason Christopher Carson It was defended on May 27, 2009 and approved by Thesis Advisor: Urvashi Surti Ph.D Associate Professor Pathology School of Medicine University of Pittsburgh Committee Member: Eleanor Feingold Ph.D. Associate Professor Human Genetics Graduate School of Public Health University of Pittsburgh Committee Member: Susanne M. Gollin Ph.D. Professor Human Genetics Graduate School of Public Health University of Pittsburgh ii Copyright © by Jason C. Carson 2009 iii Urvashi Surti, Ph.D. A COMPREHENSIVE EXAMINATION OF HUMAN TRIPLOIDY AND DIPLOID/TRIPLOID MIXOPLOIDY Jason C. Carson, MS University of Pittsburgh, 2009 Triploidy is the presence of 69 chromosomes instead of the normal diploid number of 46 and can occur in a complete form or in a mixoploid state in which there are populations of diploid and triploid cells in the same individual. The extra haploid set can be of paternal or maternal origin. Triploidy is one of the most common chromosome aberrations seen in 1-2% of all recognized pregnancies and can lead to partial mole which can in turn lead to serious complications for the mother and fetus. Given the high incidence of chromosome abnormalities including triploidy and its impact on individuals with chromosomally abnormal pregnancies, a greater understanding of their etiology has a potential to contribute greatly to public health by enhancing the management and possible future prevention.
    [Show full text]
  • Face Processing in Turner Syndrome
    Face Processing in Turner syndrome Kate Louise Elgar Thesis submitted for the degree of Doctor of Philosophy September 2002 Institute of Child Health, University College London ProQuest Number: 10015080 All rights reserved INFORMATION TO ALL USERS The quality of this reproduction is dependent upon the quality of the copy submitted. In the unlikely event that the author did not send a complete manuscript and there are missing pages, these will be noted. Also, if material had to be removed, a note will indicate the deletion. uest. ProQuest 10015080 Published by ProQuest LLC(2016). Copyright of the Dissertation is held by the Author. All rights reserved. This work is protected against unauthorized copying under Title 17, United States Code. Microform Edition © ProQuest LLC. ProQuest LLC 789 East Eisenhower Parkway P.O. Box 1346 Ann Arbor, Ml 48106-1346 Abstract This thesis explored the influence of X-linked genes on the development of face- processing abilities. It assessed face-processing abilities in women with Turner syndrome (TS) who have just one, instead of two, X-chromosomes. Study One assessed the nature and severity of face processing deficits by applying a diverse battery of neuropsychological tests to 45,X"’ and control females. Women with TS performed at below average levels in terms of face and emotion recognition (particularly fearful faces) despite processing faces in a typical configurai manner. Study Two found equivalent deficits in 45,X*^ women. Using Voxel Based Morphometry, Study Three found evidence for increased volume of the amygdalae and orbito-frontal cortices in women with TS. Because males, like 45,X females, have a single X-chromosome, Study Four sought to identify whether there was any sexual dimorphism in face processing abilities - there was not.
    [Show full text]
  • The X's and O's of Turner's Syndrome
    Susan Charney Andrea Smillie Copyright ©1987 by Susan Charney Printed in Toronto, Canada First Edition: 1983 Second Edition: 1987 Turner's Syndrome Society of Canada 7777 Keele St. 2nd Floor Concord, Ontario L4K 1Y7 Ph: (905) 660-7766 Fax: (905) 660-7450 Toll Free 1 800 465-6744 This printing has been made possible by a generous donation from Genentech Canada. Acknowledgements The Turner's Syndrome Society would like to thank effort and expertise to the creation and revision o{ this the following Individuals who have contributed their time, booklet: Diane Plumridge for the inspiration and help provided by her booklet Good Things Come In Small Packages. Dr. Johannes Nielsen for his contribution to the sections on physical characteristics and disclosure. Medical Resources J.M. Berg, M.D. C. Cowell, M.D. H.A. Gardner, M.D. E. Greenglass, Ph.D. J. Holland, M.D. I.E. Pearce, Ph.D. J. Rovet, Ph.D. Artistic Contributions Christopher Costello-Cover Karen Fenwick-Drawing Rhonda Reich-Diagrams Editors Michael Bockner Hedy Weiss Special thanks to all those who participated in group discussions, contributed their experiences and sent in their surveys. These individuals helped to make this booklet truly representative of the concerns of those with Turner's Syndrome Introduction The Turner's Syndrome Society of Canada was formed to provide much needed services for those with Turner's Syndrome and their families. The Society held its inaugural meeting in 1981 with only 3 mem bers present. It has since grown to include hundreds of members from all over the world. People with disorders that are not common or well known often feel isolated.
    [Show full text]
  • Technical Details Congential Anomaly Statistics 2017- Technical Details
    National Congential Anomaly and Rare Disease Registration Service Congenital anomaly statistics 2017- technical details Congential anomaly statistics 2017- technical details About Public Health England Public Health England exists to protect and improve the nation’s health and wellbeing, and reduce health inequalities. We do this through world-leading science, knowledge and intelligence, advocacy, partnerships and the delivery of specialist public health services. We are an executive agency of the Department of Health and Social Care, and a distinct delivery organisation with operational autonomy. We provide government, local government, the NHS, Parliament, industry and the public with evidence-based professional, scientific and delivery expertise and support. Public Health England Wellington House 133-155 Waterloo Road London SE1 8UG Tel: 020 7654 8000 www.gov.uk/phe Twitter: @PHE_uk Facebook: www.facebook.com/PublicHealthEngland © Crown copyright 2019 You may re-use this information (excluding logos) free of charge in any format or medium, under the terms of the Open Government Licence v3.0. To view this licence, visit OGL. Where we have identified any third party copyright information you will need to obtain permission from the copyright holders concerned. Published August 2019 PHE publications PHE supports the UN gateway number: GW-473 Sustainable Development Goals 2 Congential anomaly statistics 2017- technical details Contents About Public Health England 2 Incidence and birth prevalence 4 Confidence intervals 4 Calculation of birth
    [Show full text]
  • 2003 Birmingham
    11 S1 The Advanced DNA Banking and European Journal of Human Genetics Isolation Technology – IsoCode® IsoCode is optimized lyse Cells IsoCode is available To isolate DNA Standard Card and Stix archive DNA As ID with colour indicator prepare PCR IsoCode can be used high through-put format identification of individuals you want For population screening forensic testing paternity testing • Supplement 11 1 Volume Archiving DNA, cDNA Clones and Vectors The Official Journal of the European Society of Human Genetics Biological samples dried on IsoCode can be archived indefinitely at ambi- ent temperatures. IsoCode is bactericidal, virucidal, and fungicidal. Isolation of DNA without any reagents EUROPEAN HUMAN GENETICS CONFERENCE 2003 IsoCode binds and inactivates proteins and inhibitors – but not the DNA . DNA is released from IsoCode in a simple water elution process that MAY 3 – 6, 2003, BIRMINGHAM, ENGLAND requires neither reagents nor additional costs. PROGRAMME AND ABSTRACTS High quality DNA – easy and cheap DNA eluted from IsoCode is ready for PCR, automated DNA sequencing, STR analysis, mtDNA analysis and other bio-molecular techniques. Use in a lot of fields May 2003 Ideal for drug discovery SNP libraries, epide- miological studies, human identity appli- cations, forensic samples and as back-up copy. EHGC 2003 Booth 940 Volume 11 – Supplement 1 – May 2003 U.S. Pat. #5.939.259, U.S. Pat. 6.168.922 Made under license from Whatman plc. to U.S. Pat. #5.807.527 Schleicher & Schuell BioScience GmbH · Tel. +49-55 61-79 14 63 · Fax +49-55 61-79 15 83 · D-37582 Dassel · Germany · [email protected] Schleicher & Schuell BioScience Inc.
    [Show full text]
  • EUROCAT Syndrome Guide
    JRC - Central Registry european surveillance of congenital anomalies EUROCAT Syndrome Guide Definition and Coding of Syndromes Version July 2017 Revised in 2016 by Ingeborg Barisic, approved by the Coding & Classification Committee in 2017: Ester Garne, Diana Wellesley, David Tucker, Jorieke Bergman and Ingeborg Barisic Revised 2008 by Ingeborg Barisic, Helen Dolk and Ester Garne and discussed and approved by the Coding & Classification Committee 2008: Elisa Calzolari, Diana Wellesley, David Tucker, Ingeborg Barisic, Ester Garne The list of syndromes contained in the previous EUROCAT “Guide to the Coding of Eponyms and Syndromes” (Josephine Weatherall, 1979) was revised by Ingeborg Barisic, Helen Dolk, Ester Garne, Claude Stoll and Diana Wellesley at a meeting in London in November 2003. Approved by the members EUROCAT Coding & Classification Committee 2004: Ingeborg Barisic, Elisa Calzolari, Ester Garne, Annukka Ritvanen, Claude Stoll, Diana Wellesley 1 TABLE OF CONTENTS Introduction and Definitions 6 Coding Notes and Explanation of Guide 10 List of conditions to be coded in the syndrome field 13 List of conditions which should not be coded as syndromes 14 Syndromes – monogenic or unknown etiology Aarskog syndrome 18 Acrocephalopolysyndactyly (all types) 19 Alagille syndrome 20 Alport syndrome 21 Angelman syndrome 22 Aniridia-Wilms tumor syndrome, WAGR 23 Apert syndrome 24 Bardet-Biedl syndrome 25 Beckwith-Wiedemann syndrome (EMG syndrome) 26 Blepharophimosis-ptosis syndrome 28 Branchiootorenal syndrome (Melnick-Fraser syndrome) 29 CHARGE
    [Show full text]
  • Physical Examination of Newborn by Dr Behzad Barekatain MD Assistant Professor of Pediatrics, Neonatologist Academic Member of Isfahan University of Medical Sciences
    Physical examination of Newborn By Dr behzad barekatain MD Assistant professor of pediatrics, neonatologist Academic member of isfahan university of medical sciences 1 Swelling of the eyelids is common in newborns and resolves during the first few days of life. Subconjunctival hemorrhages are common. They occur during delivery and resolve in 1 to 2 weeks. 2 The normally white sclera is evaluated for changes of color. A bluish coloration, however, is present in premature infants and in other small babies because of their very thin sclera.also presents in baby with osteogenesis imperfecta. There may also be a mucoid discharge affecting the eyes, often called a “sticky eye,” in the first few days of life, which resolves spontaneously; if more prolonged, it is often from a blocked or incompletely canalized nasolacrimal duct. The eyelids can be cleansed with sterile water. This condition must be contrasted with the erythematous, swollen eyelids with purulent eye discharge seen in conjunctivitis. 4 5 ABNORMAL RED REFLEX This is one of the most important abnormalities that requires immediate evaluation. The term leukocoria is used to describe a white pupil seen by the naked eye or during the red reflex test. Leukocoria is not a diagnosis but rather a description of an observation. Because the infant sleeps much of the time and because the pupils are small, a white pupil often is not noticed until the infant becomes more alert and active. False-positive red reflex test results are commonly due to small pupils, shifting gaze, limited patient cooperation, poor illumination from the ophthalmoscope, and examiner inexperience.
    [Show full text]